(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.

Fig. 5. Effects of Mib2 mis-expression in FCMs and its requirement in FMs to
eliminate Lmd from myotubes. In all embryos, the lateral-ventral region is
shown and anterior is to the left. (A) Mef2GAL4;
2xUAS-mib2, (B) snsGAL4; 2xUAS-mib2 and
(C) Mef2GAL4; 2xUAS-mib2-C935S-C1020S Drosophila
embryos. (A',B',C') Higher
magnification views of corresponding embryos. Note the presence in A'
and B' (but not in C') of thin (mono/bi-nucleated) myotubes
(anti-myosin staining). (D-F) Mef2GAL4; 2xUAS-mib2
embryos. (D) Duf (green) and Rols (red) co-localise to the membrane of
mini-myotubes (arrowheads) induced by overexpression of Mib2-FL. (E,F)
Overexpression promotes death (activated-Caspase 3 expression, red) of FCMs
(Kettin labelling, green) starting at stage 12 (E) and most prevalent at stage
14 (F). Mini-myotubes did not express activated-Caspase 3 (arrowhead in F).
(G,H) Late stage 13 yw and mib21
embryos, respectively, stained with anti-Connectin (red) and anti-Lmd (green).
(I) Schematic representation of late stage 13 Connectin-expressing
precursors. (J,K) Stage 16
mib21/CyO and mib21 embryos
stained with anti-Tm (red) and anti-Lmd (green). Lmd is not detected in early
precursors (G) or late myotubes (J) of wild-type embryos, but it is not
eliminated in mib21 embryos (H,K).